The immunoglobulin g degrading enzyme imlifidase for the treatment of anti-gbm disease: The good-ides 01 trial

Authors
Category Primary study
JournalJournal of the American Society of Nephrology
Year 2020
This article has no abstract
Epistemonikos ID: 038d097bb4abc76b8c1728ad99ba03e239b8867d
First added on: Feb 12, 2025